Publication Cover
Redox Report
Communications in Free Radical Research
Volume 1, 1995 - Issue 5
2
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Inhibitory effect of ebselen on the oxidation of low density lipoprotein

, , , &
Pages 357-360 | Accepted 24 Apr 1995, Published online: 13 Jul 2016
 

SUMMARY

The inhibitory effect of a synthesized glutathione peroxidase (GSHPX) mimic- ebselen, and its cofactor glutathione (GSH), on the oxidation of low density lipoprotein (LDL) induced by Cu2+ was studied by determination of hydroperoxides and thiobarbituric acid reactive substances (TBARS). Ebselen alone had a strong inhibitory effect on the oxidation of LDL. The lag time of LDL oxidation was prolonged with an increase in the concentration of ebselen. The inhibitory effect of 5 μM ebselen was equivalent to that of 50 μM α-tocopherol. When GSH was present, ebselen exhibited stronger inhibitory effect than when present alone. With 50 μM GSH, ebselen at a concentration as low as 5 μM could inhibit oxidation of LDL induced by 5 μM Cu2+ completely for at least 24 h. Ebselen at high concentrations (100 μM) decomposed hydroperoxides in pre-oxidized LDL and effectively prevented its further oxidation, but not in the present of EDTA. Low concentration of ebselen (5 μM) plus GSH (50 μM) decomposed hydroperoxides in pre-oxidized LDL whether EDTA was added or not.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.